LB 970 – Nebraska

Status: Inactive / Dead
Year Introduced: 2020

LB 970 will limit the total out of pocket costs to patients with insulin drug prescriptions to $100 per each 30 day supply, regardless of the amount or type that is needed to fulfill the prescription.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found